| Literature DB >> 35053949 |
Zhenjiang Ding1,2, Qichao Wei1, Chunmei Liu1, Hong Zhang1, Feng Huang1.
Abstract
Rigor mortis occurs in a relatively early postmortem period and is a complex biochemical process in the conversion of muscle to meat. Understanding the quality changes and biomarkers during rigor mortis can provide a theoretical basis for maintaining and improving meat quality. Herein, a tandem mass tag proteomic method is used to investigate the effects of differentially expressed proteins on the meat quality of cattle Longissimus lumborum muscle postmortem (0, 6, and 24 h). The pH, total sulfhydryl content and sarcomere length decrease significantly during storage. In contrast, meat color values (L*, a*, and b*) and the myofibril fragmentation index increase significantly. Altogether, 147 differentially expressed proteins are identified, most being categorized as metabolic enzymes, mitochondrial proteins, necroptosis and ferroptosis proteins and structural proteins. The results also reveal additional proteins that are potentially involved in rigor mortis, such as cardiac phospholamban, acetyl-coenzyme A acyltransferase, and ankyrin repeat domain 2. The current results provide proteomic insights into the changes in meat quality during rigor mortis.Entities:
Keywords: bioinformatics; meat quality; protein biomarkers; proteomics; rigor mortis
Year: 2022 PMID: 35053949 PMCID: PMC8775072 DOI: 10.3390/foods11020217
Source DB: PubMed Journal: Foods ISSN: 2304-8158
Figure 1Experimental design and workflow. TMT: tandem mass tags, HPLC-MS/MS: liquid-chromatography tandem mass spectrometry, WB: western blot.
pH and meat color of Longissimus lumborum muscles during postmortem storage.
| pH | L* | a* | b* | |
|---|---|---|---|---|
| 0 h | 6.541 ± 0.185 a | 29.066 ± 1.299 a | 8.650 ± 1.103 a | 4.864 ± 0.291 a |
| 6 h | 5.530 ± 0.164 b | 29.744 ± 1.448 a | 11.294 ± 0.865 b | 7.156 ± 1.052 b |
| 24 h | 5.224 ± 0.015 c | 34.429 ± 1.643 b | 13.997 ± 2.040 c | 9.888 ± 1.429 c |
L*, a*, and b* represent lightness, redness, and yellowness, respectively; different letters (a–c) in the same column indicate significant differences at different postmortem storage times (p < 0.05). The data were expressed as the mean ± SD.
Total sulfhydryl content, MFI (myofibril fragmentation index), and sarcomere length of Longissimus lumborum muscles during postmortem storage.
| Total Sulfhydryl Content (%) | MFI | Sarcomere Length (μm) | |
|---|---|---|---|
| 0 h | 100.00 ± 5.136 a | 52.233 ± 0.463 a | 1.278 ± 0.013 a |
| 6 h | 80.058 ± 2.362 b | 56.333 ± 0.689 b | 1.164 ± 0.020 b |
| 24 h | 67.928 ± 5.136 c | 61.000 ± 0.253 c | 1.054 ± 0.035 c |
Different letters (a–c) in the same column indicate significant differences at different postmortem storage times (p < 0.05). The data were expressed as the mean ± SD.
Figure 2Transmission electron microscopy (TEM) images of longissimus lumborum muscles during postmortem storage.
Gene ontology classification results of differentially expressed proteins of 6 h vs. 0 h PM.
| Term | Description | ||
|---|---|---|---|
| Biological Process | GO:0046031 | ADP metabolic process | 6.10 × 10−9 |
| GO:0006757 | ATP generation from ADP | 3.02 × 10−8 | |
| GO:0009132 | Nucleoside diphosphate metabolic process | 1.02 × 10−8 | |
| GO:0006165 | Nucleoside diphosphate phosphorylation | 2.03 × 10−9 | |
| GO:0046939 | Nucleotide phosphorylation | 2.03 × 10−9 | |
| GO:0046434 | Organophosphate catabolic process | 3.67 × 10−8 | |
| GO:0009135 | Purine nucleoside diphosphate metabolic process | 6.10 × 10−9 | |
| GO:0009179 | Purine ribonucleoside diphosphate metabolic process | 6.10 × 10−9 | |
| GO:0042866 | Pyruvate biosynthetic process | 3.02 × 10−8 | |
| GO:0009185 | Ribonucleoside diphosphate metabolic process | 6.10 × 10−9 | |
| Cellular Component | GO:0005903 | Brush border | 0.043 |
| GO:1990584 | Cardiac troponin complex | 0.037 | |
| GO:0043292 | Contractile fiber | 0.009 | |
| GO:0044449 | Contractile fiber part | 0.008 | |
| GO:0098850 | Extrinsic component of synaptic vesicle membrane | 0.020 | |
| GO:0097452 | GAIT complex | 0.037 | |
| GO:0031674 | I band | 0.037 | |
| GO:0030016 | Myofibril | 0.009 | |
| GO:0030017 | Sarcomere | 0.006 | |
| GO:0005861 | Troponin complex | 0.015 | |
| Molecular Function | GO:0051373 | FATZ binding | 4.58 × 10−5 |
| GO:0016866 | Intramolecular transferase activity | 2.14 × 10−4 | |
| GO:0016868 | Intramolecular transferase activity, phosphotransferases | 0.002 | |
| GO:0000287 | Magnesium ion binding | 0.006 | |
| GO:0004784 | Superoxide dismutase activity | 0.007 | |
| GO:0016532 | Superoxide dismutase copper chaperone activity | 0.007 | |
| GO:0031433 | Telethonin binding | 0.002 | |
| GO:0016740 | Transferase activity | 9.75 × 10−4 | |
| GO:0016769 | Transferase activity, transferring nitrogenous groups | 0.001 | |
| GO:0009041 | Uridylate kinase activity | 0.007 |
Gene ontology classification results of differentially expressed proteins of 24 h vs. 6 h PM.
| Term | Description | ||
|---|---|---|---|
| Biological Process | GO:0098656 | Anion transmembrane transport | 2.42 × 10−5 |
| GO:0006820 | Anion transport | 9.35 × 10−5 | |
| GO:1905039 | Carboxylic acid transmembrane transport | 3.52 × 10−4 | |
| GO:0015893 | Drug transport | 9.31 × 10−6 | |
| GO:0051234 | Establishment of localization | 3.68 × 10−4 | |
| GO:0034220 | Ion transmembrane transport | 6.68 × 10−4 | |
| GO:0006811 | Ion transport | 2.37 × 10−5 | |
| GO:0021675 | Nerve development | 3.52 × 10−4 | |
| GO:1903825 | Organic acid transmembrane transport | 3.52 × 10−4 | |
| GO:0006810 | Transport | 3.42 × 10−4 | |
| Cellular Component | GO:0031975 | Envelope | 4.82 × 10−4 |
| GO:0016021 | Integral component of membrane | 3.94 × 10−10 | |
| GO:0031301 | Integral component of organelle membrane | 5.38 × 10−4 | |
| GO:0031224 | Intrinsic component of membrane | 5.74 × 10−10 | |
| GO:0098573 | Intrinsic component of mitochondrial membrane | 5.38 × 10−4 | |
| GO:0044425 | Membrane part | 1.88 × 10−4 | |
| GO:0005740 | Mitochondrial envelope | 3.47 × 10−4 | |
| GO:0031966 | Mitochondrial membrane | 3.52 × 10−4 | |
| GO:0031967 | Organelle envelope | 4.82 × 10−4 | |
| GO:0031090 | Organelle membrane | 1.49 × 10−4 | |
| Molecular Function | GO:0022804 | Active transmembrane transporter activity | 6.62 × 10−5 |
| GO:0008509 | Anion transmembrane transporter activity | 7.26 × 10−7 | |
| GO:0046943 | Carboxylic acid transmembrane transporter activity | 3.52 × 10−4 | |
| GO:0015238 | Drug transmembrane transporter activity | 3.52 × 10−4 | |
| GO:0015318 | Inorganic molecular entity transmembrane transporter activity | 8.75 × 10−6 | |
| GO:0015075 | Ion transmembrane transporter activity | 8.75 × 10−6 | |
| GO:0008514 | Organic anion transmembrane transporter activity | 2.42 × 10−5 | |
| GO:0015291 | Secondary active transmembrane transporter activity | 2.42 × 10−5 | |
| GO:0022857 | Transmembrane transporter activity | 3.15 × 10−6 | |
| GO:0005215 | Transporter activity | 6.38 × 10−6 |
KEGG pathway enrichment of differentially expressed proteins of 6 h vs. 0 h PM.
| Pathway | Pathway Name | |
|---|---|---|
| map00220 | Arginine biosynthesis | 0.037 |
| map01230 | Biosynthesis of amino acids | 2.39 × 10−5 |
| map01200 | Carbon metabolism | 7.47 × 10−6 |
| map05204 | Chemical carcinogenesis | 0.005 |
| map00270 | Cysteine and methionine metabolism | 0.006 |
| map00982 | Drug metabolism-cytochrome P450 | 0.009 |
| map00051 | Fructose and mannose metabolism | 0.009 |
| map00052 | Galactose metabolism | 0.037 |
| map00480 | Glutathione metabolism | 0.006 |
| map00010 | Glycolysis/Gluconeogenesis | 7.77 × 10−9 |
| map04910 | Insulin signaling pathway | 0.029 |
| map04213 | Longevity regulating pathway-multiple species | 0.009 |
| map01100 | Metabolic pathways | 3.48 × 10−7 |
| map00980 | Metabolism of xenobiotics by cytochrome P450 | 0.015 |
| map00030 | Pentose phosphate pathway | 0.004 |
| map04146 | Peroxisome | 0.023 |
| map00360 | Phenylalanine metabolism | 0.037 |
| map00620 | Pyruvate metabolism | 0.001 |
| map00500 | Starch and sucrose metabolism | 0.032 |
| map00750 | Vitamin B6 metabolism | 0.007 |
KEGG pathway enrichment of differentially expressed proteins of 24 h vs. 6 h PM.
| Pathway | Pathway Name | |
|---|---|---|
| map05010 | Alzheimer’s disease | 0.013 |
| map04020 | Calcium signaling pathway | 8.00 × 10−5 |
| map04022 | cGMP-PKG signaling pathway | 4.70 × 10−4 |
| map05166 | HTLV-I infection | 0.002 |
| map05016 | Huntington’s disease | 0.002 |
| map04657 | IL-17 signaling pathway | 0.044 |
| map04211 | Longevity regulating pathway | 0.044 |
| map05144 | Malaria | 0.027 |
| map04217 | Necroptosis | 0.039 |
| map00190 | Oxidative phosphorylation | 0.006 |
| map05012 | Parkinson’s disease | 6.80 × 10−5 |
| map04742 | Taste transduction | 0.005 |
| map00130 | Ubiquinone and other terpenoid–quinone biosynthesis | 0.014 |
Figure 3(A) Protein-protein interaction networks of differentially expressed proteins of 6 h vs. 0 h PM. (B) Protein-protein interaction networks of differentially expressed proteins of 24 h vs. 6 h PM.
Figure 4(A) Validation of the differentially expressed proteins of 0 h vs. 6 h PM by western blotting. (B) Validation of the differentially expressed proteins of 6 h vs. 24 h PM by western blotting.
Validation of the differentially expressed proteins (PKM, TNNT1, COX5A, FIS1, COX4I1, and NDUFB11) by western blotting.
| Accession | Gene Names | TMT (6/0 h) | WB (6/0 h) | TMT (24/6 h) | WB (24/6 h) | ||||
|---|---|---|---|---|---|---|---|---|---|
| FC | FC | FC | FC | ||||||
| A5D984 | PKM | 0.64 | 0 | 0.64 | 0.0056 | ||||
| Q8MKH6-2 | TNNT1 | 1.47 | 2.15 × 10−33 | 1.57 | 0.0024 | ||||
| P00426 | COX5A | 2.28 | 0.0001 | 1.72 | 0.0017 | ||||
| Q3T0I5 | FIS1 | 0.78 | 2.58 × 10−6 | 0.65 | 0.0031 | ||||
| P00423 | COX4I1 | 0.49 | 3.34 × 10−36 | 0.61 | 0.0318 | ||||
| Q8HXG5 | NDUFB11 | 0.87 | 0.0387 | 0.66 | 0.0216 | ||||
FC indicates the fold change of each differentially expressed protein of 6/0 h PM or 24/6 h PM. TMT: tandem mass tags; WB: western blotting.